MX2010001081A - Derivados de 1-oxo-1,2-dihidroisoquinolina-5-carboxamidas y de 4-oxo-3,4-dihidroquinazolina-8-carboxamidas, su preparacion y su uso terapeutico. - Google Patents
Derivados de 1-oxo-1,2-dihidroisoquinolina-5-carboxamidas y de 4-oxo-3,4-dihidroquinazolina-8-carboxamidas, su preparacion y su uso terapeutico.Info
- Publication number
- MX2010001081A MX2010001081A MX2010001081A MX2010001081A MX2010001081A MX 2010001081 A MX2010001081 A MX 2010001081A MX 2010001081 A MX2010001081 A MX 2010001081A MX 2010001081 A MX2010001081 A MX 2010001081A MX 2010001081 A MX2010001081 A MX 2010001081A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- group
- carboxamides
- oxo
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
Abstract
La invención se refiere a los derivados de 1-oxo-1 2-dihidroisoquinolein-5-carboxamidas y de 4-oxo-3,4-dihidroquinazo lin-8-carboxamidas, de fórmula general (I) en la que: R1 representa un átomo de hidrógeno, un grupo alquilo(C1-C10), cicloalquilo(C3-C7), (CH2)n-alquenilo(C1-C6), (CH2)n-alquinilo(C1-C6), alquilo(C1-C6)-Z-alquilo(C1-C6), en el que Z representa un heteroátomo elegido entre O, N y S(O)m, o bien R1 representa un grupo COOR, S(O)mR un arilo o un aralquilo, los grupos alquilo(C1-C10), cicloalquilo(C3-C7), (CH2)-alquenilo(C1-C6), (CH2)-alquinilo(C4-C6), alquilo(C1-C6)-Z-alquilo(C1-C5), arilo o aralquilo ; R2 representa uno o varios grupos elegidos entre un átomo de hidrógeno, un átomo de halógeno, un grupo alquilo(C1-C6), cicloalquilo(C3-C7), alquenilo(C1-C6), alquinilo(C1-C6), alquilo(C1-C6)-Z-alquilo(C1-C6), en el que Z representa un heteroátomo elegido entre O, N y S(O)m, o bien R2 representa un grupo haloalquilo(C1-C6), haloalcoxi(C1-C6), hidroxi, alcoxi(C1-C6), nitro, ciano, amino, un grupo NR7R8, COOR, CONR7R8, OCOalquilo(C1-C6), S(O)m-NR7R8, un grupo arilo; R4 y R5 representan, independientemente uno del otro, un átomo de hidrógeno, o bien R4 y R5 forman con el átomo de carbono que les lleva un ciclo saturado que contiene de 3 a 6 átomos de carbono y que contienen opcionalmente de 0 a 1 heteroátomo elegido entre O, N o S; R6 representa un grupo elegido entre un átomo de hidrógeno, un átomo de halógeno, un grupo alquilo(C1-C6), cicloalquilo(C3-C7), cicloalquilo(C3-C7)alquilo(C1-C6), un grupo haloalquilo(C1-C6), nitro, amino, un grupo NR7R8, COOR, un grupo NR7(SO2)R8, CONR7R8, un grupo arilo; X representa un átomo de carbono o un átomo de nitrógeno; m representa un número entero comprendido entre 0 y 2 y n representa un número entero comprendido entre 1 y 6. Procedimiento de preparación y aplicación en terapéutica.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705500A FR2919286A1 (fr) | 2007-07-27 | 2007-07-27 | Derives de derives de 1-oxo-1,2-dihydroisoquinoleine-5- carboxamides et de 4-oxo-3,4-dihydroquinazoline-8- carboxamides,leur preparation et leur application en therapeutique. |
| PCT/FR2008/001109 WO2009044018A2 (fr) | 2007-07-27 | 2008-07-25 | Dérivés de 1-0x0-1,2-dihydroisoquinoleine-5-carboxamides et de 4-oxo-3,4-dihydroquinazoline-8-carboxamides, leur préparation et leur application en thérapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010001081A true MX2010001081A (es) | 2010-03-24 |
Family
ID=39106736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010001081A MX2010001081A (es) | 2007-07-27 | 2008-07-25 | Derivados de 1-oxo-1,2-dihidroisoquinolina-5-carboxamidas y de 4-oxo-3,4-dihidroquinazolina-8-carboxamidas, su preparacion y su uso terapeutico. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8030320B2 (es) |
| EP (1) | EP2185523A2 (es) |
| JP (1) | JP2010534640A (es) |
| KR (1) | KR20100047294A (es) |
| CN (1) | CN101790518A (es) |
| AU (1) | AU2008306762A1 (es) |
| BR (1) | BRPI0814177A2 (es) |
| CA (1) | CA2694313A1 (es) |
| CO (1) | CO6290668A2 (es) |
| EA (1) | EA201070196A1 (es) |
| FR (1) | FR2919286A1 (es) |
| MA (1) | MA31629B1 (es) |
| MX (1) | MX2010001081A (es) |
| NZ (1) | NZ582995A (es) |
| WO (1) | WO2009044018A2 (es) |
| ZA (1) | ZA201000583B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2687750C (en) * | 2007-07-06 | 2016-10-18 | Boehringer Ingelheim International Gmbh | Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
| FR2919285B1 (fr) * | 2007-07-27 | 2012-08-31 | Sanofi Aventis | Derives de 1-oxo-isoindoline-4-carboxamides et de 1-oxo- 1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur preparation et leur application en therapeutique. |
| AU2013229229B2 (en) * | 2012-03-07 | 2017-10-19 | Institute Of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| CN103087047B (zh) * | 2012-12-10 | 2016-12-21 | 南京农业大学 | 一种含二氢异喹啉基团的吡咯烷‑2,4‑二酮类化合物、制备方法及其应用 |
| NO3044221T3 (es) | 2013-09-11 | 2018-07-21 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005520791A (ja) * | 2001-11-08 | 2005-07-14 | イーラン ファーマスーティカルズ、インコーポレイテッド | Ｎ，ｎ’−置換−１，３−ジアミノ−２−ヒドロキシプロパン誘導体 |
| AU2003211428A1 (en) | 2002-02-22 | 2003-09-09 | Teijin Limited | Pyrrolopyrimidine derivative |
| GB0309221D0 (en) | 2003-04-23 | 2003-06-04 | Glaxo Group Ltd | Novel compounds |
| GB0328900D0 (en) | 2003-12-12 | 2004-01-14 | Glaxo Group Ltd | Novel compounds |
| US7745470B2 (en) | 2005-03-10 | 2010-06-29 | Bristol-Myers Squibb Company | Isophthalates as beta-secretase inhibitors |
| GB0506562D0 (en) | 2005-03-31 | 2005-05-04 | Glaxo Group Ltd | Novel compounds |
-
2007
- 2007-07-27 FR FR0705500A patent/FR2919286A1/fr active Pending
-
2008
- 2008-07-25 EP EP08835688A patent/EP2185523A2/fr not_active Withdrawn
- 2008-07-25 BR BRPI0814177-0A2A patent/BRPI0814177A2/pt not_active IP Right Cessation
- 2008-07-25 MX MX2010001081A patent/MX2010001081A/es not_active Application Discontinuation
- 2008-07-25 JP JP2010517452A patent/JP2010534640A/ja not_active Withdrawn
- 2008-07-25 WO PCT/FR2008/001109 patent/WO2009044018A2/fr active Application Filing
- 2008-07-25 CN CN200880104537A patent/CN101790518A/zh active Pending
- 2008-07-25 KR KR1020107004332A patent/KR20100047294A/ko not_active Application Discontinuation
- 2008-07-25 EA EA201070196A patent/EA201070196A1/ru unknown
- 2008-07-25 AU AU2008306762A patent/AU2008306762A1/en not_active Abandoned
- 2008-07-25 NZ NZ582995A patent/NZ582995A/en not_active IP Right Cessation
- 2008-07-25 CA CA2694313A patent/CA2694313A1/fr not_active Abandoned
-
2010
- 2010-01-26 CO CO10007694A patent/CO6290668A2/es not_active Application Discontinuation
- 2010-01-26 ZA ZA2010/00583A patent/ZA201000583B/en unknown
- 2010-01-26 US US12/693,598 patent/US8030320B2/en not_active Expired - Fee Related
- 2010-02-24 MA MA32646A patent/MA31629B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100047294A (ko) | 2010-05-07 |
| ZA201000583B (en) | 2011-04-28 |
| MA31629B1 (fr) | 2010-08-02 |
| US20100197706A1 (en) | 2010-08-05 |
| US8030320B2 (en) | 2011-10-04 |
| EA201070196A1 (ru) | 2010-08-30 |
| CA2694313A1 (fr) | 2009-04-09 |
| FR2919286A1 (fr) | 2009-01-30 |
| NZ582995A (en) | 2012-04-27 |
| BRPI0814177A2 (pt) | 2015-01-20 |
| AU2008306762A1 (en) | 2009-04-09 |
| JP2010534640A (ja) | 2010-11-11 |
| CN101790518A (zh) | 2010-07-28 |
| EP2185523A2 (fr) | 2010-05-19 |
| WO2009044018A2 (fr) | 2009-04-09 |
| CO6290668A2 (es) | 2011-06-20 |
| WO2009044018A3 (fr) | 2009-06-18 |
| WO2009044018A9 (fr) | 2010-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0300743A2 (hu) | Heteroarilszármazékok és alkalmazásuk gyógyszerként | |
| MY139988A (en) | Macrocylic inhibitors of hepatitis c virus | |
| HUP0302468A2 (hu) | Alfa V integrin receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények | |
| MX2010006202A (es) | Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| RS91404A (en) | Derivatives of n-(phenyl(piperidin-2- yl)benzamide, the preparation method thereof and application of same in therapeutics | |
| CY1116183T1 (el) | Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης | |
| TW200612920A (en) | Novel imidazolidine derivatives | |
| MX2009002802A (es) | Derivados de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparacion y su aplicacion en terapeutica. | |
| ATE453639T1 (de) | Phenylsubstituierte pyrimidinverbindungen zur verwendung als kinasehemmer | |
| HUP0400699A2 (hu) | Fenetanolaminszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
| EA200970461A1 (ru) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ | |
| HUP0202799A2 (hu) | Herbicid hatású izoxazolinszármazékok és azt tartalmazó készítmény | |
| RS20060315A (en) | Derivatives of n-/phenyl(pyrrolidine-2-yl) methyl/benzamide, and n- /(azepan-2-yl)phenylmethyl/benzamide, preparation method thereof and application of same in therapeutics | |
| MX2010001081A (es) | Derivados de 1-oxo-1,2-dihidroisoquinolina-5-carboxamidas y de 4-oxo-3,4-dihidroquinazolina-8-carboxamidas, su preparacion y su uso terapeutico. | |
| PL368409A1 (en) | Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a? receptor and their use as medicaments | |
| TW200609220A (en) | Tetrahydroisoquinolylsulphonamide derivatives, their preparation and their use in therapeutics | |
| GB0610765D0 (en) | Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such | |
| NZ336623A (en) | 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines for use in the treatment and prevention of disorders of the central nervous system | |
| MX2008016558A (es) | Preparacion y aplicacion terapéutica de derivados de 2-benzoil-imidazopiridinas. | |
| MY183326A (en) | New dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| MX2010006446A (es) | Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
| FR2942625B1 (fr) | Derives indoliques pour le traitement de maladies neurodegeneratives | |
| WO2003008412A3 (en) | Hetero-bicyclic crf antagonists | |
| GEP20115240B (en) | Indole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0102492A2 (hu) | Amino-indanon származékok alkalmazása NF-kB transzkripciós faktor inhibitor hatású gyógyszerkészítmények előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |